Second Sight Medical Products Profit Margin 2013-2018 | EYES
Current and historical gross margin, operating margin and net profit margin for Second Sight Medical Products (EYES) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Second Sight Medical Products net profit margin as of December 31, 2018 is -508.9%.
|Second Sight Medical Products Annual Profit Margins
|Second Sight Medical Products Quarterly Profit Margins
||Medical Instruments Manufacturing
Second Sight Medical Products, Inc. is a medical device company. It develops, manufactures, and markets implantable prosthetic devices to restore some functional vision to blind patients. The Company provides Argus II system, an implantable neurostimulation device for the treatment of outer retinal degenerations, such as retinitis pigmentosa. Second Sight Medical Products, Inc. is headquartered in Sylmar, California.